CagriSema is being studied for use in adults with obesity or overweight, with or without type 2 diabetes, to support weight loss and improve blood sugar levels
Ongoing Monitoring and Safety Your bloodwork tracks growth hormone levels, IGF-1 production, fasting glucose, insulin sensitivity, and liver function to catch any adverse effects early
If you reconstitute a 30 mg vial with sterile water and plan to draw doses over several weeks, you are creating a contamination risk that increases with every injection
Both promote wound healing and tissue repair
A mildly acidic to near-neutral pH window is generally preferred, and compatibility trials with the specific preservative system, chelator, and surfactant package are recommended